SCHEDULE 13D/A: Dr. Phillip Frost and Affiliated Trusts Reaffirm Significant Stake in OPKO Health, Inc. with Latest SEC Filing

Dr. Phillip Frost and his affiliated trusts have filed Amendment No. 26 to their Schedule 13D, reaffirming their substantial beneficial ownership of 31.7% in OPKO Health, Inc., primarily due to a change in the issuer's outstanding shares.

Summary

• Dr. Phillip Frost, along with Frost Gamma Investments Trust and Frost Nevada Investments Trust, collectively beneficially own 252,399,406 shares of OPKO Health, Inc. Common Stock.
• This represents approximately 31.7% of the Issuer's outstanding shares, based on 793,051,553 shares outstanding as of April 3, 2025, and including exercisable options.
• Dr. Frost's individual holdings include 3,068,951 shares and options to acquire 2,600,000 shares exercisable within 60 days.
• Frost Gamma Investments Trust, controlled by Dr. Frost, holds 213,751,448 shares, constituting approximately 27.0% of the outstanding shares.
• Frost Nevada Investments Trust, also controlled by Dr. Frost, holds 30,127,177 shares, constituting approximately 3.8% of the outstanding shares.
• The Phillip and Patricia Frost Philanthropic Foundation, Inc., which is controlled by Dr. Frost and his wife, owns an additional 2,851,830 shares of Common Stock.
• This filing is Amendment No. 26 to the Schedule 13D, primarily filed solely as a result of a change in OPKO Health's number of outstanding shares of Common Stock.
• In the last 60 days prior to the filing, Gamma Trust acquired a total of 517,434 shares of Common Stock on the open market for an aggregate purchase price of approximately $882,360.00, with prices ranging from $1.645 to $1.745 per share.

Sentiment

Score: 5

Explanation: The document is a neutral, factual compliance filing regarding beneficial ownership. While the insider buying by Gamma Trust is a minor positive, the overall nature of the filing is regulatory and does not contain significant operational or financial news for the company itself.

Positives

• Continued significant insider ownership by Dr. Phillip Frost and affiliated entities, indicating strong alignment with shareholder interests.
• Recent open market purchases by Gamma Trust (517,434 shares for approximately $882,360.00) demonstrate continued confidence in the company by a major beneficial owner.

Risks

• High concentration of ownership by Dr. Frost and his affiliated entities (31.7%), which could significantly influence corporate decisions and potentially limit the influence of other shareholders.

Future Outlook

The document notes that Dr. Frost's ownership position excludes restricted stock units that give him a contingent right to receive up to 500,000 shares of Common Stock, which will not begin to vest until July 2026.

Industry Context

This filing is a routine compliance update regarding significant beneficial ownership and does not provide broader industry trends or competitive analysis.

Related Party Transactions

• The Phillip and Patricia Frost Philanthropic Foundation, Inc., which is controlled by Dr. Frost and his wife, owns 2,851,830 shares of Common Stock, representing a related party holding.

Stakeholder Impact

• Shareholders: Provides transparency regarding significant insider ownership and recent open market purchases by a major beneficial owner, which can be viewed positively as a sign of continued confidence.

Next Steps

• Dr. Frost's restricted stock units are expected to begin vesting in July 2026.

Key Dates

Recommendation

Keywords

OPKO Health, Phillip Frost, Schedule 13D, Beneficial Ownership, Insider Ownership, Common Stock, SEC Filing, Investment Trust, Shareholder Stake